Iteos Therapeutics Stock Options Expiring on 17th of April

ITOS Stock  USD 7.83  0.23  2.85%   

Iteos Therapeutics Corporate Management

Matthew GallChief OfficerProfile
Matthew MBAChief OfficerProfile
Ryan BakerHead RelationsProfile
Joanne MDChief OfficerProfile
Adi OsovskyExecutive LegalProfile

Additional Tools for Iteos Stock Analysis

When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.